PTC
AMGN icon

Philadelphia Trust Company’s Amgen AMGN Stock Holding History

Philadelphia Trust Company’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.5M Buy
29,844
+2,736
+10% +$975K 0.74% 33
2025
Q4 		$8.87M Sell
27,108
-631
-2% -$200K 0.61% 34
2025
Q3 		$7.83M Sell
27,739
-1,276
-4% -$370K 0.55% 38
2025
Q2 		$8.1M Sell
29,015
-607
-2% -$172K 0.62% 36
2025
Q1 		$9.23M Sell
29,622
-6,375
-18% -$1.88M 0.79% 34
2024
Q4 		$9.38M Sell
35,997
-2,529
-7% -$750K 0.69% 36
2024
Q3 		$12.4M Sell
38,526
-1,483
-4% -$485K 0.9% 28
2024
Q2 		$12.5M Buy
40,009
+432
+1% +$127K 0.97% 26
2024
Q1 		$11.3M Buy
39,577
+541
+1% +$158K 0.9% 32
2023
Q4 		$11.2M Buy
39,036
+3,918
+11% +$1.07M 1.06% 25
2023
Q3 		$9.44M Sell
35,118
-4,506
-11% -$1.12M 0.97% 26
2023
Q2 		$8.8M Buy
39,624
+589
+2% +$137K 0.83% 30
2023
Q1 		$9.44M Buy
39,035
+16,080
+70% +$3.95M 0.96% 23
2022
Q4 		$6.03M Buy
22,955
+250
+1% +$67K 0.65% 45
2022
Q3 		$5.12M Buy
22,705
+130
+0.6% +$31.5K 0.58% 49
2022
Q2 		$5.49M Buy
22,575
+620
+3% +$152K 0.56% 47
2022
Q1 		$5.31M Sell
21,955
-1,727
-7% -$397K 0.42% 56
2021
Q4 		$5.33M Sell
23,682
-41,664
-64% -$8.79M 0.39% 56
2021
Q3 		$13.9M Sell
65,346
-4,965
-7% -$1.14M 1.02% 27
2021
Q2 		$17.1M Sell
70,311
-2,090
-3% -$514K 1.18% 23
2021
Q1 		$18M Sell
72,401
-453
-0.6% -$108K 1.38% 21
2020
Q4 		$16.8M Buy
72,854
+7,322
+11% +$1.69M 1.37% 23
2020
Q3 		$16.7M Buy
65,532
+3,645
+6% +$903K 1.61% 22
2020
Q2 		$14.6M Sell
61,887
-5,095
-8% -$1.16M 1.54% 23
2020
Q1 		$13.6M Sell
66,982
-3,395
-5% -$742K 1.71% 22
2019
Q4 		$17M Sell
70,377
-695
-1% -$153K 1.46% 24
2019
Q3 		$13.8M Sell
71,072
-6,568
-8% -$1.26M 1.28% 27
2019
Q2 		$14.3M Buy
77,640
+1,775
+2% +$318K 1.26% 25
2019
Q1 		$14.4M Buy
75,865
+22,835
+43% +$4.36M 1.27% 26
2018
Q4 		$10.3M Sell
53,030
-21,681
-29% -$4.23M 1.1% 30
2018
Q3 		$15.5M Buy
74,711
+35
+0% +$6.9K 1.27% 24
2018
Q2 		$13.8M Sell
74,676
-6,501
-8% -$1.15M 1.23% 22
2018
Q1 		$13.8M Sell
81,177
-3,116
-4% -$572K 1.15% 26
2017
Q4 		$14.7M Sell
84,293
-9,284
-10% -$1.64M 1.15% 26
2017
Q3 		$17.4M Sell
93,577
-1,240
-1% -$220K 1.43% 22
2017
Q2 		$16.3M Sell
94,817
-792
-0.8% -$129K 1.39% 23
2017
Q1 		$15.7M Sell
95,609
-4,659
-5% -$774K 1.29% 27
2016
Q4 		$14.7M Sell
100,268
-1,550
-2% -$233K 1.17% 37
2016
Q3 		$17M Sell
101,818
-9,717
-9% -$1.64M 1.47% 26
2016
Q2 		$17M Sell
111,535
-13,301
-11% -$2.07M 1.47% 27
2016
Q1 		$18.7M Buy
124,836
+8,125
+7% +$1.21M 1.6% 23
2015
Q4 		$18.9M Sell
116,711
-38,177
-25% -$6M 1.58% 27
2015
Q3 		$21.4M Buy
154,888
+130,376
+532% +$20.6M 1.93% 15
2015
Q2 		$160K Sell
24,512
-164,765
-87% -$26.4M 0.59% 49
2015
Q1 		$30.3M Sell
189,277
-50,115
-21% -$7.89M 2.31% 8
2014
Q4 		$38.1M Sell
239,392
-74,031
-24% -$11.5M 3.07% 4
2014
Q3 		$44M Sell
313,423
-9,620
-3% -$1.26M 2.73% 6
2014
Q2 		$38.2M Buy
323,043
+23,068
+8% +$2.67M 2.38% 13
2014
Q1 		$37M Buy
299,975
+12,659
+4% +$1.54M 2.33% 15
2013
Q4 		$32.8M Buy
287,316
+16,439
+6% +$1.87M 2.09% 19
2013
Q3 		$30.3M Sell
270,877
-1,588
-0.6% -$172K 2.09% 17
2013
Q2 		$26.9M Buy
+272,465
New +$28.3M 2.01% 22

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Philadelphia Trust Company's AMGN Position: Q1 2026 in Review

Philadelphia Trust Company increased its Amgen (AMGN) stake by 10% in Q1 2026, buying an estimated $975K and bringing the position to 29,844 shares worth $10.5M. The position accounts for 0.74% of the portfolio, ranked #33.

Philadelphia Trust Company first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $44M in Q3 2014. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Philadelphia Trust Company held 29,844 shares of Amgen worth $10.5M as of Q1 2026.
  • Philadelphia Trust Company bought 2,736 Amgen shares in Q1 2026, an estimated $975K.
  • Amgen made up 0.74% of Philadelphia Trust Company's portfolio in Q1 2026, its #33 holding.
  • Philadelphia Trust Company first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • Philadelphia Trust Company's Amgen position peaked at $44M in Q3 2014.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Philadelphia Trust Company's 13F filing for Q1 2026, filed 13 May 2026.